Rheumatoid arthritis disease activity assessed by patient-reported outcomes and flow cytometry before and after an additional dose of COVID-19 vaccine

Ann Rheum Dis. 2022 Jul;81(7):1045-1048. doi: 10.1136/annrheumdis-2022-222232. Epub 2022 Feb 15.
No abstract available

Keywords: COVID-19; T-lymphocyte subsets; antirheumatic agents; arthritis; rheumatoid; vaccination.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Letter

MeSH terms

  • Antirheumatic Agents* / therapeutic use
  • Arthritis, Rheumatoid* / drug therapy
  • COVID-19 Vaccines
  • COVID-19* / prevention & control
  • Flow Cytometry
  • Humans
  • Patient Reported Outcome Measures

Substances

  • Antirheumatic Agents
  • COVID-19 Vaccines